Emergency department network for tracking new infections
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
This program collects health information and samples from people who come to emergency rooms with sudden illnesses to spot new infectious threats and learn how they're managed.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11514937 on NIH RePORTER |
What this research studies
If you come to a participating emergency department with an acute illness, staff may collect clinical information and biological samples around the clock to look for emerging infections. The network connects many EDs across the U.S., with attention to diverse and underserved communities, so data reflect real-world care. Collected samples are analyzed in labs to identify pathogens, study risk factors, and monitor things like vaccine protection among frontline workers. The network has been used for rapid surveillance during outbreaks, allowing quick public health responses.
Who could benefit from this research
Good fit: Ideal candidates are people seeking emergency care for sudden infectious symptoms at one of the participating U.S. emergency departments, including those from diverse or underserved backgrounds.
Not a fit: People who are healthy, have non-infectious chronic conditions, or who do not visit a participating emergency department are unlikely to be directly involved or benefit from participation.
Why it matters
Potential benefit: If successful, this work could help detect outbreaks sooner, improve emergency care guidelines, and guide public health policies that protect patients.
How similar studies have performed: EMERGEncy ID NET has a long track record of peer-reviewed publications and successfully ran rapid COVID-19 surveillance projects, so the approach has prior success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Talan, David Andrew — University of California Los Angeles
- Study coordinator: Talan, David Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.